Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 28, 2025
Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) is pleased to announce additional high-grade intercepts and the second batch of results from the 2025 winter diamond drill program (“Winter …
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Sono-Tek Reports Strong Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 28, 2025
-Reports Fourth Consecutive Quarter of Revenue above $5 million -FY 2025 Revenue Growth of 4% YOY - Backlog Remains Strong at $8.6 Million - Projecting Continued Revenue Growth and Profitability in the First Half of Fiscal Year 2026 -Conference Today at 11 …
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 28, 2025
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
May 28, 2025
FLORHAM PARK, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster …
BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that the company will present groundbreaking research across five sessions at the 72nd American Society for Mass …
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
GlobeNewswire
·
May 28, 2025
SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the “ …
Leading Global Manufacturer Requests HPQ’s First Batch of Fumed Silica for Evaluation
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders …
Un fabricant de premier plan a demandé un lot de silice pyrogénée issu du plus récent essai de HPQ, à des fins d’évaluation
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de procédés critiques …
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
GlobeNewswire
·
May 28, 2025
If approved, tebipenem HBr could be the first oral carbapenem antibiotic for US patients with complicated urinary tract infections (cUTIs) An estimated 2.9 million cases of cUTIs are treated annually in the US1 with many cases requiring hospitalization, …
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
Velocity comes out of stealth with $10M to power the Velocity of Money
GlobeNewswire
·
May 28, 2025
London, May 28, 2025 (GLOBE NEWSWIRE) -- Velocity announces a $10M pre-seed funding round and emerges from stealth to launch the Stablecoin Payment Account. The round was led by Activant Capital, with participation from Fuel Ventures, Triton Capital, …
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
GlobeNewswire
·
May 28, 2025
Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugation of 177Lu-DOTA …
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
GlobeNewswire
·
May 28, 2025
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and safety data, enobosarm 3mg will advance as …
Goliath Mobilizes For Its Largest Drill Program Of 40,000 Meters With 9 Rigs On The Extensive Surebet High-Grade Gold Discovery That Remains Wide Open Golddigger Property, Golden Triangle, B.C.
GlobeNewswire
·
May 28, 2025
Goliath is embarking on its largest drill program to date that is 100% focused on the extensive Surebet high-grade gold discovery totaling 40,000 meters with 9 rigs based on the positive results from the 2024 drill season which has greatly improved the …
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewswire
·
May 28, 2025
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an …
Canadian Credit Market Reaches $2.5 Trillion in Outstanding Balances, with Gen Z Canadians Accounting for 10% of Credit Growth
GlobeNewswire
·
May 28, 2025
Key findings from TransUnion report: New-to-credit Canadians led to greater credit participation, accounting for $2.6 billion in new credit balances in Q1 2025 Subprime consumers are almost twice as likely to go delinquent within 12 months of opening new …
Jiayin Group Inc. to Release First Quarter 2025 Unaudited Financial Results on Wednesday, June 4, 2025
GlobeNewswire
·
May 28, 2025
SHANGHAI, China, May 28, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it will release its unaudited financial results for the first quarter of 2025 before …
[Latest] Global Green and Bio Polyols Market Size/Share Worth USD 12.65 Billion by 2034 at a 9.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, SWOT Analysis)
GlobeNewswire
·
May 28, 2025
Austin, TX, USA, May 28, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Green and Bio Polyols Market Size, Trends and Insights By Type (Polyester Polyols, Polyether Polyols), By Application (PU Rigid Foam, CASE, …
Acronis Appoints Eduardo García Sancho as Iberia Country Manager
GlobeNewswire
·
May 28, 2025
MADRID, May 28, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, is pleased to announce the appointment of Eduardo García Sancho as Iberia Country Manager. In this role, García Sancho will lead the regional team in …